ANRO R&D to Revenue
Alto Neuroscience, Inc. Common Stock · R&D to Revenue
ANRO R&D to Revenue
Latest reported0.00%period ending
ANRO FY R&D/Revenue (3985.71% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
ANRO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 3,985.7143% |